NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...

However, further research is needed to fully understand the complex mechanisms of axon regeneration and how they can be utilized for spinal cord injury treatments. Lipin1 is an enzyme that ...

Rehabilitation is an essential component of restoring hand function, and occupational therapy is central to this process ... and function after a spinal cord injury is a complex process.

A key to their investigation was to elucidate the critical involvement of microglia in axonal degeneration post-spinal cord axon injury. Microglia are primary immune cells in the central nervous ...

Spinal injuries are so hard to treat because the central nervous system’s cells ... worldwide research to find a treatment for spinal cord injury, there is still no clinically available ...

A collaborative study in neuroscience, spearheaded by a research team of the Hong Kong University of Science and Technology ...

Eric LeGrand Single Barrel Bourbon is a Kentucky Straight Bourbon Whiskey bottled at 104 proof. It was produced at Green ...

Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...

NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.

That's why Eric LeGrand Spirits — co-founded by the namesake business owner and advocate for those who are paralyzed after he sustained a spinal cord injury playing football for Rutgers ...